Traws Pharma

Trawsfynydd is an antiviral drug development company dedicated to reducing illness and mortality in patients with respiratory viral diseases, including influenza and COVID-19. Trawsfynydd combines exceptional medicinal chemistry with artificial intelligence and machine learning tools to guide and accelerate the drug development process. We are particularly committed to developing best-in-class treatments for the elderly, immunocompromised individuals, and other populations vulnerable to respiratory viral infections, who are at higher risk of severe disease and death due to such infections.